Abstract:
UNASSIGNED: Lymphedema is chronic limb swelling from lymphatic dysfunction and is currently incurable. Breast-cancer related lymphedema (BCRL) affects up to 5 million Americans and occurs in one-third of breast cancer survivors following axillary lymph node dissection. Compression remains the mainstay of therapy. Surgical management of BCRL includes excisional procedures to remove excess tissue and physiologic procedures to attempt improve fluid retention in the limb. The purpose of this review is to highlight surgical management strategies for preventing and treating breast cancer-related lymphedema.
UNASSIGNED: Immediate lymphatic reconstruction (ILR) is a microsurgical technique that anastomoses disrupted axillary lymphatic vessels to nearby veins at the time of axillary lymph node dissection (ALND) and has been reported to reduce lymphedema rates from 30% to 4-12%.
UNASSIGNED: Postsurgical lymphedema remains incurable. Surgical management of lymphedema includes excisional procedures and physiologic procedures using microsurgical technique. Immediate lymphatic reconstruction has emerged as a prophylactic strategy to prevent lymphedema in breast cancer patients.
摘要:
■淋巴水肿是由淋巴功能障碍引起的慢性肢体肿胀,目前无法治愈。乳腺癌相关淋巴水肿(BCRL)影响多达500万美国人,并且在腋窝淋巴结清扫后发生在三分之一的乳腺癌幸存者中。压迫仍然是治疗的主要手段。BCRL的外科治疗包括切除手术以去除多余的组织和生理手术以试图改善肢体中的液体潴留。这篇综述的目的是强调预防和治疗乳腺癌相关淋巴水肿的手术管理策略。
■立即淋巴重建(ILR)是一种显微外科技术,可以在腋窝淋巴结清扫(ALND)时将腋窝淋巴管与附近静脉吻合,据报道可以将淋巴水肿的发生率从30%降低到4-12%。
■术后淋巴水肿仍无法治愈。淋巴水肿的外科治疗包括使用显微外科技术的切除手术和生理手术。立即淋巴重建已成为预防乳腺癌患者淋巴水肿的预防策略。